{
  "id": 18026372,
  "title": "Ultragenyx to lay off 20% of employees, scrap a Wilson disease gene therapy",
  "url": "https://urgent.news/2026/11/03/ultragenyx-to-lay-off-20-of-employees-scrap-a-wilson-disease-gene",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-03T21:55:33.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/ultragenyx-to-lay-off-20-of-employees-scrap-a-wilson-disease-gene-therapy/"
  },
  "original_language": "en",
  "account": null,
  "summary": "After a whirlwind third quarter that saw two FDA approvals but a major setback in Angelman syndrome, Ultragenyx is laying off staff for the second time this year. The California biopharma",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}